In the bone tissues of patients with BS, PLOD2 variant decreased the activity of LH2b, resulting in insufficient hydroxylation of the collagen telopeptide Lys residues, which in turn leads to a decrease in the level of bone collagen pyridinoline cross-linking (1, 12, 37). Here, PLOD2 is linked to Bloom syndrome.